There is a right way and a wrong way to inform a patient about a switch from the reference product to a biosimilar, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.
Related Keywords
Laura Wingate , Crohn Colitis Foundation , Colitis Foundation , Biosimilars , Switching , Nocebo , Education ,
comparemela.com © 2020. All Rights Reserved.